Drugs / ColiSorB
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07179523 | Sep → Oct 2023 | — | Sara Omar | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Colisorb | “ColiSorB® is a novel biomimetic adhesive, coagulant-free hemostatic sponge engineered for dental and surgical applications.” NCT07179523 ↗1“A newly developed hemostatic gelatin sponge called Colisorb was used” NCT07179523 ↗ |